BCG Albumin Assay Kit

Details for Product No. ABIN1000254
Antigen
Application
Biochemical Assay (BCA)
Options
Sample Type Plasma, Serum, Urine
Specificity 0.01 g/dL
Characteristics Sensitive and accurate. Use as little as 5 µL samples. Detection range 0.01 g/dL (1.5µM) to 5 g/dL (750µM) albumin in 96-well plate assay.
Simple and high-throughput. The procedure involves addition of a single working reagent and incubation for 5 min. Can be readily automated as a high-throughput assay in 96-well plates for thousands of samples per day.
Improved reagent stability and versatility. The optimized formulation has greatly enhanced reagent and signal stability. Cuvet or 96-well plate assay.
No interference in biological samples.
No pretreatments are needed. Assays can be directly performed on raw biological samples i.e., in the presence of lipid and protein.
Components Reagent: 50 mL. Albumin Standard: 1 mL 5 g/dL BSA.
Material not included Pipeting devices and accessories (e.g. 5 µL). Clear bottom 96-well plates (e.g. Corning Costar) and plate reader. Spectrophotometer and cuvets for measuring OD at 620nm.
Target Name (Antigen)
Background Quantitative determination of albumin by bromcresol green BCG method at 620nm.
Procedure: 5 min.

Albumin is the most abundant plasma protein in human. It accounts for about 60% of the total serum protein. Albumin plays important physiological roles, including maintenance of colloid osmotic pressure, binding of key substances such as long-chain fatty acids, bile acids, bilirubin, haematin, calcium and magnesium. It has anti-oxidant and anticoagulant effects, and also acts as a carrier for nutritional factors and drugs, as an effective plasma pH buffer. Serum albumin is a reliable prognostic indicator for morbidity and mortality, liver disease, nephritic syndrome, malnutrition and protein-losing enteropathies. High levels are associated with dehydration. Simple, direct and automation-ready procedures for measuring albumin concentration in biological samples are becoming popular in Research and Drug Discovery. This BCG albumin assay kit is designed to measure albumin directly in biological samples without any pretreatment. The improved method utilizes bromcresol green that forms a colored complex specifically with albumin. The intensity of the color, measured at 620nm, is directly proportional to the albumin concentration in the sample. The optimized formulation substantially reduces interference by substances in the raw samples.
Application Notes Direct Assays: albumin in serum, plasma, urine, biological preparations.
Drug discovery/Pharmacology: effects of drugs on albumin metabolism.
Protocol Procedure using 96-well plate:
1. Dilute standards in distilled water. Dilute serum and plasma samples 2 fold. Transfer 5 µL diluted standards and diluted samples to wells of a clear bottom plate. Store diluted standards at -20°C for future use.
2. Add 200 µL working reagent and tap lightly to mix. Avoid bubble.
3. Incubate 5 min at room temperature and read optical density at 570- 670nm (peak absorbance at 620nm).

Procedure using cuvette:
1. Transfer 20 µL Blank, Standards and samples to appropriately labeled tubes. Add 1000 µL working reagent and tap lightly to mix. Incubate 5 min at room temperature.
2. Transfer to cuvet and read optical density at 620nm. Important: if sample OD is higher than the OD for standard, dilute samples with distilled water and repeat the assay.
Reagent Preparation

Important: bring reagent to room temperature before use.

Calculation of Results

Subtract blank OD (water, #8) from the standard OD values and plot the OD against standard concentrations. Use the standard curve to determine the sample albumin concentration.
Conversions: 0.1 g/dL albumin equals 15 µM, 0.1% or 1000 ppm.

Restrictions For Research Use only
Storage 4 °C
Supplier Images
Biochemical Assay (BCA) image for BCG Albumin Assay Kit (ABIN1000254) BCG Albumin Assay Kit
Product cited in: Doi, Rekha, Ahmed, Okada, Roy, El Arifeen, Ekström, Raqib, Wagatsuma: "Association between calcium in cord blood and newborn size in Bangladesh." in: The British journal of nutrition, Vol. 106, Issue 9, pp. 1398-407, 2011 (PubMed).

Euhus, Bu, Xie, Sarode, Ashfaq, Hunt, Xia, OShaughnessy, Grant, Arun, Dooley, Miller, Flockhart, Lewis: "Tamoxifen downregulates ets oncogene family members ETV4 and ETV5 in benign breast tissue: implications for durable risk reduction." in: Cancer prevention research (Philadelphia, Pa.), Vol. 4, Issue 11, pp. 1852-62, 2011 (PubMed).

Irani, Pomerantseva, Hart, Sundback, Neville, Vacanti: "Mechanical dissociation of swine liver to produce organoid units for tissue engineering and in vitro disease modeling." in: Artificial organs, Vol. 34, Issue 1, pp. 75-8, 2010 (PubMed).

Zhang, Thomas, Marshall, Kernan, Su, Zheng, Takano, Saido, Eddy: "Nicotinic acetylcholine receptor α1 promotes calpain-1 activation and macrophage inflammation in hypercholesterolemic nephropathy." in: Laboratory investigation, a journal of technical methods and pathology, Vol. 91, Issue 1, pp. 106-23, 2010 (PubMed).

Roberts, Goralski, Renton, Julien, Webber, Sleno, Volmer, Hall: "Effect of acute inflammatory brain injury on accumulation of morphine and morphine 3- and 6-glucuronide in the human brain." in: Critical care medicine, Vol. 37, Issue 10, pp. 2767-74, 2009 (PubMed).

Osborn, Verdrengh, Stossel, Tarkowski, Bokarewa: "Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritis." in: Arthritis research & therapy, Vol. 10, Issue 5, pp. R117, 2008 (PubMed).

Cosgrove, Meehan, Delimont, Pozzi, Chen, Rodgers, Tempero, Zallocchi, Rao: "Integrin alpha1beta1 regulates matrix metalloproteinases via P38 mitogen-activated protein kinase in mesangial cells: implications for Alport syndrome." in: The American journal of pathology, Vol. 172, Issue 3, pp. 761-73, 2008 (PubMed).

Sullivan, Harris, Palmer: "Convection and hemoglobin-based oxygen carrier enhanced oxygen transport in a hepatic hollow fiber bioreactor." in: Artificial cells, blood substitutes, and immobilization biotechnology, Vol. 36, Issue 4, pp. 386-402, 2008 (PubMed).

Kain, Exner, Brandes, Ziebermayr, Cunningham, Alderson, Davidovits, Raab, Jahn, Ashour, Spitzauer, Sunder-Plassmann, Fukuda, Klemm, Rees, Kerjaschki: "Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis." in: Nature medicine, Vol. 14, Issue 10, pp. 1088-96, 2008 (PubMed).

Helsby, Lo, Sharples, Riley, Murray, Spells, Dzhelai, Simpson, Findlay: "CYP2C19 pharmacogenetics in advanced cancer: compromised function independent of genotype." in: British journal of cancer, Vol. 99, Issue 8, pp. 1251-5, 2008 (PubMed).

Zhang, Bernatoniene, Bagrade, Pollard, Mitchell, Paton, Finn: "Serum and mucosal antibody responses to pneumococcal protein antigens in children: relationships with carriage status." in: European journal of immunology, Vol. 36, Issue 1, pp. 46-57, 2006 (PubMed).

Wang, de Caestecker, Kopp, Mitu, Lapage, Hirschberg: "Renal bone morphogenetic protein-7 protects against diabetic nephropathy." in: Journal of the American Society of Nephrology : JASN, Vol. 17, Issue 9, pp. 2504-12, 2006 (PubMed).

Klatzkin, Morrow, Light, Pedersen, Girdler: "Associations of histories of depression and PMDD diagnosis with allopregnanolone concentrations following the oral administration of micronized progesterone." in: Psychoneuroendocrinology, Vol. 31, Issue 10, pp. 1208-19, 2006 (PubMed).

Lee, Seo, Reger, Spees, Pulin, Olson, Prockop: "Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, Issue 46, pp. 17438-43, 2006 (PubMed).

Did you look for something else?